Election committee for Vitrolife AB (publ)
GOTHENBURG, Sweden, Oct. 4, 2024 /PRNewswire/ --
The following people have been appointed as members of the election committee for Vitrolife AB for the Annual General Meeting in 2025:
Niels Jacobsen, appointed by William Demant Invest A/S
Patrik Tigerschiöld, appointed by Bure Equity AB
Patricia Hedelius, appointed by AMF Fonder & Pension
Jón Sigurdsson, Chairman of the Board
The appointments have been made in accordance with the instructions regarding principles for the appointment of the company election committee which were determined at the Annual General Meeting of Vitrolife AB on April 25, 2024.
The Annual General Meeting of Vitrolife AB (publ) will be held on April 29, 2025 in Gothenburg.
Shareholders who wish to have an item considered at the Annual General Meeting can submit a request to the Board to this effect. Such a request for an item to be considered is to be sent to Vitrolife AB (publ), Att: Chairman of the Board, Box 9080, 400 92 Gothenburg, and must have been received by the Board no later than seven weeks before the Annual General Meeting, or otherwise in such good time that the matter, where necessary, can be included in the notice to attend the Annual General Meeting.
Gothenburg, October 4, 2024
VITROLIFE AB (publ)
Contact:
Jón Sigurdsson, Chairman of the Board, email: jon@emblamedical.com
Patrik Tolf, CFO, phone +46 (0) 31 766 90 21
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/vitrolife-ab--publ-/r/election-committee-for-vitrolife-ab--publ-,c4047069
The following files are available for download:
Election committee for Vitrolife AB (publ) |
View original content:https://www.prnewswire.com/news-releases/election-committee-for-vitrolife-ab-publ-302267722.html
SOURCE Vitrolife AB (publ)
Upcoming Life Sciences Events
- December 2024
- Pre-JPM Partnering Week
- Spectrum of Stem Cell Neuronal Models and Their Purpose Fit
- January 2025
- San Francisco: 8th Annual Neuroscience Innovation Forum
Latest company news
First patient dosed in EXIST Phase 2a study in Parkinson's disease